Stuart Shanler
Aclaris Therapeutics
Chief Scientific Officer
Dr. Shanler is the chief scientific officer at Aclaris Therapeutics. He is a board-certified dermatologist and dermatologic/Mohs micrographic surgeon. Prior to co-founding Aclaris, Dr. Shanler was a co-founder and chief scientific officer of Vicept Therapeutics (acquired by Allergan in 2011) and was co-inventor of the Vicept technology. Dr. Shanler also co-founded Aspect Pharmaceuticals, a dermatology specialty (development-stage) pharmaceutical company, where he served as chief executive officer and chief medical officer.
Dr. Shanler received a dual B.A. degree in biology (comparative vertebrate physiology) and the biological basis of behavior from the University of Pennsylvania, from which he graduated with honors and distinction in research for work performed on cytochrome oxidase. He received his M.D. from the Albany Medical College of Union University, where he received the Albert M. Yunich Award for clinical excellence in medicine. He completed residency in internal medicine at the Beth Israel Medical Center of New York and then served as attending physician and clinical instructor in internal medicine at Elmhurt General Hospital and the Mount Sinai School of Medicine.
Dr. Shanler completed residency in dermatology at the State University of New York at Buffalo and served as fellow in cutaneous oncology and investigational laser therapeutics/photodynamic therapy (PDT) at the Roswell Park Cancer Institute, where his research focused on PDT and the development of topical and systemic drug/laser systems for the treatment of various skin cancers. He then served as assistant clinical professor of dermatology at Roswell Park prior to returning to Philadelphia, where he completed an ACMS-approved fellowship in Mohs micrographic surgery and dermatologic surgery under the direction of Dr. Anthony Benedetto.
Dr. Shanler has received numerous awards for his clinical research; has presented his research and lectured at local, national and international conferences; and has co-written, edited and contributed to numerous peer-reviewed articles and textbook chapters over the last 20 years.